Carregant...
LINKAGE TO PRIMARY CARE FOR PERSONS FIRST RECEIVING INJECTABLE NALTREXONE DURING INPATIENT OPIOID DETOXIFICATION
INTRODUCTION: Opioid use disorders commonly require ongoing medication-assisted treatment to reduce relapse following discharge from inpatient detoxification programs. Naltrexone, an opioid antagonist, is an increasingly popular treatment option in its once-monthly injectable form (XR-NTX). The aim...
Guardat en:
| Publicat a: | J Subst Abuse Treat |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4818184/ https://ncbi.nlm.nih.gov/pubmed/26920817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2016.01.007 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|